AIRLINK 165.36 Decreased By ▼ -10.19 (-5.8%)
BOP 10.39 Decreased By ▼ -0.62 (-5.63%)
CNERGY 7.83 Decreased By ▼ -0.46 (-5.55%)
FCCL 45.65 Decreased By ▼ -1.58 (-3.35%)
FFL 15.12 Decreased By ▼ -0.90 (-5.62%)
FLYNG 26.48 Decreased By ▼ -0.83 (-3.04%)
HUBC 135.28 Decreased By ▼ -7.04 (-4.95%)
HUMNL 12.85 Decreased By ▼ -0.45 (-3.38%)
KEL 4.19 Decreased By ▼ -0.25 (-5.63%)
KOSM 5.47 Decreased By ▼ -0.43 (-7.29%)
MLCF 59.43 Decreased By ▼ -2.37 (-3.83%)
OGDC 213.07 Decreased By ▼ -13.70 (-6.04%)
PACE 5.41 Decreased By ▼ -0.36 (-6.24%)
PAEL 42.01 Decreased By ▼ -2.79 (-6.23%)
PIAHCLA 17.05 Decreased By ▼ -0.83 (-4.64%)
PIBTL 9.93 Decreased By ▼ -0.54 (-5.16%)
POWER 11.79 Decreased By ▼ -0.23 (-1.91%)
PPL 174.79 Decreased By ▼ -11.13 (-5.99%)
PRL 34.36 Decreased By ▼ -2.80 (-7.53%)
PTC 22.70 Decreased By ▼ -1.35 (-5.61%)
SEARL 93.75 Decreased By ▼ -6.54 (-6.52%)
SILK 1.15 No Change ▼ 0.00 (0%)
SSGC 36.11 Decreased By ▼ -2.40 (-6.23%)
SYM 13.48 Decreased By ▼ -1.27 (-8.61%)
TELE 7.12 Decreased By ▼ -0.61 (-7.89%)
TPLP 10.21 Decreased By ▼ -0.82 (-7.43%)
TRG 60.93 Decreased By ▼ -5.07 (-7.68%)
WAVESAPP 10.28 Decreased By ▼ -0.69 (-6.29%)
WTL 1.28 Decreased By ▼ -0.07 (-5.19%)
YOUW 3.70 Decreased By ▼ -0.08 (-2.12%)
BR100 12,314 Decreased By -512.5 (-4%)
BR30 36,508 Decreased By -2353.5 (-6.06%)
KSE100 114,909 Decreased By -3882.2 (-3.27%)
KSE30 35,541 Decreased By -1237.5 (-3.36%)

Pakistan’s pharmaceutical companies Citi Pharma Limited (CPHL), Martin Dow, and Chinese pharmaceutical giant Kingbo Pharmatec, have signed a Memorandum of Understanding (MoU) to develop and manufacture new biotech/biologic products.

“This partnership is aimed at reducing Pakistan’s reliance on imported medicines by enabling the local production of this essential product for both domestic use and export,” said CPHL in its notice to the Pakistan Stock Exchange (PSX) on Tuesday.

CPHL said that under the MoU, the three pharmaceutical companies will jointly establish a state-of-the-art manufacturing facility in Indonesia.

Pakistan’s Citi Pharma commences nutraceutical exports to US

“Strategically located to meet the needs of both the Pakistani market and international customers, this facility will adhere to the highest global quality standards. This collaboration is not only set to enhance Pakistan’s pharmaceutical capabilities but will also contribute significantly to the growth of the global pharmaceutical industry,” read the notice.

Citi Pharma disclosed that Kingbo Pharmatec will lead the technical aspects of this partnership, overseeing the establishment of the manufacturing plant.

“In collaboration with Citi Pharma and Martin Dow, Kingbo will also help unlock new export opportunities, expanding the product’s reach across international markets,” the company said.

Citi said the latest initiative aligns with its vision, which aims to introduce advanced biologics and biotechnology products to Pakistan.

“By producing the product locally, this venture will reduce healthcare costs, save foreign exchange spent on imports, and strengthen Pakistan’s position in the global pharmaceutical market,” it said.

Moreover, the partnership is expected to drive a positive economic impact by reducing medicine costs, conserving foreign exchange, and opening new revenue streams through exports.

Days ago, CPHL announced a strategic partnership with Mersi Farma, an Indonesian pharmaceutical entity, to establish Active Pharmaceutical Ingredient (API) manufacturing facilities and expand its nutraceutical market in Indonesia.

Comments

200 characters
Tariff Dec 10, 2024 11:09pm
How is setting a plant in Indonesia good for Pakistan economy and exports??? Shouldn’t it be the other way round.
thumb_up Recommended (0) reply Reply
abdulrasheed Danwar Feb 28, 2025 07:58pm
I didn't enjoy this news. Manufacturing facility should have been in Pakistan. Thanks.
thumb_up Recommended (0) reply Reply